An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

Clinical trial NCT02545101 · COMPLETED

Trial details

NCT number: NCT02545101
Sponsor: Otsuka Pharmaceutical Europe Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Hyponatremia Syndrome of Inappropriate ADH (SIADH) Secretion

Start date: 2015-11-01
Primary completion: 2016-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.